Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.11 EUR | -0.98% | +4.78% | -17.03% |
02/05 | Poseida Therapeutics to Receive Up to $600 Million in Cancer Gene Therapy Research, Development Deal With Xyphos | MT |
01/05 | Malin Corp investee signs agreement with Astellas Pharma | AN |
Sales 2024 | 1,604B 10.48B 9.74B 874B | Sales 2025 * | 1,663B 10.87B 10.1B 906B | Capitalization | 2,793B 18.25B 16.96B 1,522B |
---|---|---|---|---|---|
Net income 2024 | 17.04B 111M 104M 9.29B | Net income 2025 * | 102B 667M 620M 55.62B | EV / Sales 2024 | 1.84 x |
Net Debt 2024 * | 503B 3.29B 3.06B 274B | Net Debt 2025 * | 512B 3.35B 3.11B 279B | EV / Sales 2025 * | 1.99 x |
P/E ratio 2024 |
173
x | P/E ratio 2025 * |
27.5
x | Employees | 14,484 |
Yield 2024 |
4.26% | Yield 2025 * |
4.77% | Free-Float | 98.83% |
Latest transcript on Astellas Pharma Inc.
1 day | -0.98% | ||
1 week | +4.78% | ||
Current month | +4.07% | ||
1 month | -4.11% | ||
3 months | -11.55% | ||
6 months | -21.30% | ||
Current year | -17.03% |
Managers | Title | Age | Since |
---|---|---|---|
Naoki Okamura
CEO | Chief Executive Officer | 61 | 01/86/01 |
Kitamura Atsushi
DFI | Director of Finance/CFO | 52 | 01/11 |
Kenji Yasukawa
CHM | Chairman | 63 | 01/86/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Takashi Tanaka
BRD | Director/Board Member | 67 | 01/21/01 |
Mamoru Sekiyama
BRD | Director/Board Member | 74 | 01/17/01 |
Kenji Yasukawa
CHM | Chairman | 63 | 01/86/01 |
Date | Price | Change | Volume |
---|---|---|---|
03/24/03 | 9.11 | -0.98% | 1,000 |
02/24/02 | 9.2 | +5.09% | 200 |
30/24/30 | 8.754 | -0.14% | 0 |
29/24/29 | 8.766 | +0.83% | 0 |
26/24/26 | 8.694 | -0.09% | 2,500 |
Delayed Quote Deutsche Boerse AG, May 04, 2024 at 01:19 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B | |
-3.40% | 157B |
- Stock Market
- Equities
- 4503 Stock
- YPH Stock